Exai Bio

SEO and website consulting for Exai Bio, a Palo Alto startup that is leveraging A.I. to detect cancer with liquid biopsy tests.

• Cell-free orphan noncoding RNAs and AI enable early detection of invasive breast cancer and ductal carcinoma in situ
• AI-Based Early Detection and Subtyping of Non-Small Cell Lung Cancer from Blood Samples Using Orphan Non-Coding RNAs
• Detection of early-stage cancers using circulating orphan non-coding RNAs in blood